1. Home
  2. OI vs BLTE Comparison

OI vs BLTE Comparison

Compare OI & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OI
  • BLTE
  • Stock Information
  • Founded
  • OI 1903
  • BLTE 2018
  • Country
  • OI United States
  • BLTE United States
  • Employees
  • OI N/A
  • BLTE N/A
  • Industry
  • OI Containers/Packaging
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • OI Consumer Discretionary
  • BLTE Health Care
  • Exchange
  • OI Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • OI 2.0B
  • BLTE 2.1B
  • IPO Year
  • OI N/A
  • BLTE 2022
  • Fundamental
  • Price
  • OI $14.02
  • BLTE $60.48
  • Analyst Decision
  • OI Buy
  • BLTE Strong Buy
  • Analyst Count
  • OI 8
  • BLTE 4
  • Target Price
  • OI $15.88
  • BLTE $96.67
  • AVG Volume (30 Days)
  • OI 1.0M
  • BLTE 30.8K
  • Earning Date
  • OI 07-29-2025
  • BLTE 08-08-2025
  • Dividend Yield
  • OI N/A
  • BLTE N/A
  • EPS Growth
  • OI N/A
  • BLTE N/A
  • EPS
  • OI N/A
  • BLTE N/A
  • Revenue
  • OI $6,505,000,000.00
  • BLTE N/A
  • Revenue This Year
  • OI $1.90
  • BLTE N/A
  • Revenue Next Year
  • OI $1.28
  • BLTE N/A
  • P/E Ratio
  • OI N/A
  • BLTE N/A
  • Revenue Growth
  • OI N/A
  • BLTE N/A
  • 52 Week Low
  • OI $9.23
  • BLTE $43.70
  • 52 Week High
  • OI $14.34
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • OI 61.21
  • BLTE 46.26
  • Support Level
  • OI $13.48
  • BLTE $58.55
  • Resistance Level
  • OI $13.90
  • BLTE $62.49
  • Average True Range (ATR)
  • OI 0.36
  • BLTE 1.81
  • MACD
  • OI -0.00
  • BLTE -0.40
  • Stochastic Oscillator
  • OI 91.67
  • BLTE 26.19

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: